📢 #Europace #CardioTwitter

🤔Is AF Termination a good end-point in patients with persistent atrial fibrillation ❓

See this multicenter study with 887 pts from 10 🇨🇳centers❗️

🆓📚👉doi.org/10.1093/europa…

Giulio Conte Francesco Santoro, MD, PhD Marco Vitolo Ⓜ️ Xiaodong Zhang (Andy), MD, PhD, FHRS, FACC Dominik Linz

Thank you to everyone who made this possible! David Haines- you have touched so many lives .. we are most grateful! Corewell Health Beaumont, Royal Oak - Cardiology Fellowship Heart Rhythm Society

I feel deeply honored that our multicenter registry has been accepted for publication in #Europace Europace Editor-in-Chief which was presented as LBCT in #EHRA2024 by my friend Henry D. Huang I would like to thank to all co-authors Roderick Tung Tom De Potter Roman Piotrowski Timothy Markman

Dr. Wilber Su Peter Weiss Roderick Tung Michael Zawaneh EP-Beijing Anzhen

Among patients with obesity-related heart failure with preserved ejection fraction & type 2 diabetes, semaglutide produced greater reductions in symptoms, physical limitations & body weight than placebo at 1 year. Full STEP-HFpEF DM trial results: nej.md/3TPKpUC

#ACC24

Congrats Thomas Jared Bunch on 10 years! That went fast! A job well done my friend🙏

#QSQ

BREAKING: From Berlin, Lucas Boersma sits down with Prash Sanders to discuss his #LBCT presented at #EHRA2024 on the First in Human Experience with Volt PFA. See the full interview here #EPeeps ➡️ bit.ly/3vLalc9

BREAKING: From Berlin, Lucas Boersma sits down with Vivek Y. Reddy to discuss his #LBCT presented at #EHRA2024 on the First in Human Series of Single-Shot PFA Catheter. See the full interview here #EPeeps ➡️ bit.ly/49Bs4jW

Congratulations ⁦David Callans⁩ on the new edition and preserving a lifelong legacy for future generations! Thank you for including us in the Bible of EP🙏

Go UAZ Medicine - Phoenix! Congrats to our fellows #ACC24

Will this contemporary trial change guidelines and registries? Exciting new science out of American College of Cardiology

Presented at #ACC24 :

FULL REVASC: In a registry-based trial, FFR-guided PCI of nonculprit lesions did not result in a lower risk of a composite of death from any cause, myocardial infarction, or unplanned revascularization than culprit-lesion-only PCI. nej.md/3xj5b7u

Good morning #ehra2024 and #ACC2024

Here is my take on the DanGer Shock trial. It's positive.

That's good. But let's be careful in applying these results to patients.

medscape.com/viewarticle/10…

Prophylactic VT ablation in RCT on 60 CTO patients. Significant reduction in time to first ICD therapy in this great study from Slovenja. Congrats! #EHRA2024

This is the study I wanted to do when I was pursuing an IC career path.

Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled

*NEW*

#EHRA2024 /Heart Rhythm Society /APHRS Official /LAHRS expert consensus statement on catheter and surgical ablation of #atrialfibrillation

🔗academic.oup.com/europace/artic…

#simultaneouspublication
#SimPub

See this excellent🧵from Stefan Simović below!

Total solar eclipse in Cleveland. Happy to have a short down time in between cases to capture this! Cleveland Clinic

Excited to share that HIS-CRT is over 50% enrolled! Incredible team effort! Roderick Tung Kenneth Ellenbogen Jacob Koruth Robert Schaller Gaurav A. Upadhyay Suneet Mittal Parikshit S Sharma, MD, MPH, FACC, FHRS Jim Cheung Pugal Vijayaraman Dan Lustgarten MDPhD

Standing room only, with a long entry line outside, for a late Saturday session devoted to anatomy, mechanisms, and evaluation of PVCs. This is not a picture of EHRA but #ACC2024 ! Great to see so much interest beyond EPs. Featuring Jim Cheung Kalyanam Shivkumar MD PhD Wendy Tzou.